RN7SL394P

Across TCGA pan-cancer cohorts, RN7SL394P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RN7SL394P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL394P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL394P is over-expressed in tumor, although a few such as LUSC and KIRC show the opposite, repressed pattern.

LUAD, BRCA, and KIRP are the cancer types where RN7SL394P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL394P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.262	.003	5	view →
BRCA	All	II,III,IV	+0.148	.020	4	view →
KIRP	All	All	+0.048	.020	3	view →
ESCA	All	All	+0.222	.004	2	view →
LUSC	All	All	−0.037	.024	2	view →
KIRC	Female	III,IV	−0.075	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RN7SL394P–LUAD

Open the LUAD breakdown →